Growth Metrics

BridgeBio Pharma (BBIO) Goodwill & Intangibles (2019 - 2025)

BridgeBio Pharma (BBIO) has disclosed Goodwill & Intangibles for 6 consecutive years, with $28.1 million as the latest value for Q4 2025.

  • Quarterly Goodwill & Intangibles rose 17.35% to $28.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.1 million through Dec 2025, up 17.35% year-over-year, with the annual reading at $28.1 million for FY2025, 17.35% up from the prior year.
  • Goodwill & Intangibles hit $28.1 million in Q4 2025 for BridgeBio Pharma, down from $28.8 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $46.2 million in Q3 2021 to a low of $15.0 million in Q4 2021.
  • Historically, Goodwill & Intangibles has averaged $27.5 million across 5 years, with a median of $27.8 million in 2025.
  • Biggest YoY gain for Goodwill & Intangibles was 91.41% in 2022; the steepest drop was 36.56% in 2022.
  • Year by year, Goodwill & Intangibles stood at $15.0 million in 2021, then skyrocketed by 91.41% to $28.7 million in 2022, then decreased by 8.33% to $26.3 million in 2023, then fell by 9.09% to $23.9 million in 2024, then grew by 17.35% to $28.1 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for BBIO at $28.1 million in Q4 2025, $28.8 million in Q3 2025, and $29.5 million in Q2 2025.